The president of the Parc Taulí Healthcare Corporation Consortium, Dolors Costa, accompanied by the director of the Oncology service, Dr. Miquel Seguí, yesterday collected the check for €27.114 raised in the 14th edition of the Corro Contra el Càncer race, organized by the sports organization We Run.
The charity race was a success with 2.420 registered participants, 28% more than the previous year.
All the money raised will go towards funding a research project at the Parc Taulí Research and Innovation Institute (I3PT) focused onstudy of the genetics of uterine cancers to improve treatment and prognosis.
The project, entitled “Study through next-generation sequencing (NGS) of the mutational profile of endometrial carcinoma”, is led by professionals from Parc Taulí and aims to expand the study of molecular alterations in endometrial tumors to advance towards a more personalized, effective and better tolerated precision oncology. The study allows identify genetic alterations in tumors that can provide relevant prognostic information and help decide which treatment is most appropriate for each patient after surgery.
The project has already begun to be applied to the first patients, but one of the main challenges is the cost of the reagents necessary to carry out these molecular studies. In this sense, the Funds raised with the race will allow all patients who need to undergo surgery at Parc Taulí for endometrial cancer to benefit from this technology..
I run against cancer and a leading solidarity and sports initiative in Sabadell uniting citizenship, health and research with a common goal, in the words of its organizers: to make the disease visible, talk about it without taboos and obtain more financial resources for the fight against cancer.
